Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aptevo Therapeutics (APVO) Return on Sales (2016 - 2022)

Aptevo Therapeutics (APVO) has disclosed Return on Sales for 8 consecutive years, with 0.33% as the latest value for Q4 2022.

  • Quarterly Return on Sales rose 24.0% to 0.33% in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 0.33% through Dec 2022, up 25.0% year-over-year, with the annual reading at 0.33% for FY2022, 25.0% up from the prior year.
  • Return on Sales hit 0.33% in Q4 2022 for Aptevo Therapeutics, up from 0.12% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.76% in Q2 2020 to a low of 0.34% in Q4 2019.
  • Historically, Return on Sales has averaged 0.1% across 5 years, with a median of 0.05% in 2020.
  • Biggest five-year swings in Return on Sales: plummeted -565bps in 2018 and later surged 110bps in 2020.
  • Year by year, Return on Sales stood at 0.01% in 2018, then tumbled by -5646bps to 0.34% in 2019, then soared by 114bps to 0.05% in 2020, then surged by 78bps to 0.09% in 2021, then surged by 267bps to 0.33% in 2022.
  • Business Quant data shows Return on Sales for APVO at 0.33% in Q4 2022, 0.12% in Q3 2022, and 0.07% in Q2 2022.